ReviewReviews in endocrine & metabolic disorders2026
Too much vitamin D? a drug safety review.
Review in Reviews in endocrine & metabolic disorders, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed, 1 synthesis or guideline pooled it.
- The 2024 Endocrine Society Guideline on Vitamin D: Comprehensive Summary and Critical Appraisal.Nutrients · 2026Pooled it
- Updated perspectives on vitamin D deficiency, screening, supplementation and clinical guidance.Cardiovascular diabetology. Endocrinology reports · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Vitamin D is an essential pro-hormone that helps to regulate mineral metabolism and skeletal health. Epidemiological data suggest that many individuals have insufficient serum levels of 25-hydroxy vitamin D, the marker of vitamin D status, for most of the year. Recognition of this observation has led to replacement regimens for vitamin D that have often led to its overuse even in disorders not related to bone homeostasis. Since vitamin D toxicity is rare, safety issues related to vitamin D supplementation have not been carefully addressed recently. Overall safety issues related to administration of vitamin D pro-hormones from nutritional sources and from supplements are reviewed, along with recommendations for correct intakes. Traditional and new areas in which an improper use of vitamin D may occur are specifically addressed. Supplementation with vitamin D pro-hormones is effective and safe at usual daily, weekly or monthly doses that are recommended to maintain optimal mineral homeostasis. Monitoring is generally not mandatory once the desired level of serum 25(OH)D is obtained. However, clinical circumstances often change from year to year, in which cases confirmation of the adequacy of 25(OH)D is reasonable. When calcidiol is used, long term, monitoring is expected. Ingestion of excessive amounts of vitamin D, either through overprescribing or overdosing, is potentially harmful.
Indexed as
Identifiers
41483069What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.